Dickens P, Wei W I, Sham J S
Department of Pathology, University of Hong Kong.
Cancer. 1990 Nov 1;66(9):1924-6. doi: 10.1002/1097-0142(19901101)66:9<1924::aid-cncr2820660912>3.0.co;2-9.
Postirradiation osteosarcoma of the maxilla was seen in four Hong Kong Chinese patients treated for nasopharyngeal carcinoma. These cases represent four of 42 (9%) cases of osteosarcoma at all sites in this institution during the period 1979 to 1989, when more than 1000 patients were treated with radiotherapy for nasopharyngeal carcinoma. The latent periods varied from 8 to 11 years from completion of radiotherapy treatment to development of osteosarcoma. The radiation dosage varied from 6000 to 6280 cGy in three of the patients. These cases fit the criteria for diagnosis of postirradiation sarcomas. Maxillary osteosarcomas after irradiation for nasopharyngeal carcinoma do not appear to have been described. The very high incidence of nasopharyngeal carcinoma (for which radiotherapy is the treatment of choice) in Hong Kong Chinese would make the occurrence of such tumors more likely in Hong Kong, although the small risk does not contraindicate the use of radiation in the treatment of nasopharyngeal carcinoma in view of its well-documented efficacy.
在接受鼻咽癌治疗的4名中国香港患者中发现了上颌骨放疗后骨肉瘤。这些病例占该机构1979年至1989年期间所有部位骨肉瘤病例的42例中的4例(9%),当时有1000多名患者接受了鼻咽癌放疗。从放疗结束到骨肉瘤发生的潜伏期为8至11年。3名患者的放射剂量为6000至6280 cGy。这些病例符合放疗后肉瘤的诊断标准。鼻咽癌放疗后上颌骨骨肉瘤似乎尚未见报道。中国香港人鼻咽癌的发病率非常高(放疗是首选治疗方法),这使得这类肿瘤在香港更有可能发生,尽管鉴于放疗的疗效已得到充分证明,这种小风险并不妨碍在鼻咽癌治疗中使用放疗。